Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Over-reactive immune system kills young adults during pandemic flu

06.12.2010
On November 19, Jason Martin returned to the Medical Intensive Care Unit (MICU) at Vanderbilt University Medical Center for the first time since he nearly died there during last year's H1N1 flu pandemic. The tall and burly Warren County, TN, ambulance worker – a 30-year-old, father of three young children – broke down and hugged some of the nurses he recognized.

"I got sick on September 12 and didn't come out of it for the next 20 days. I am just so grateful I came through," Martin said, wiping his eyes.

Martin was among the first wave of critically ill middle Tennesseans, hit hard by the H1N1 flu pandemic in late 2009. A hallmark of pandemic flu throughout history, including the H1N1 pandemic, has been its ability to make healthy young and middle-aged adults seriously ill and even kill this population in disproportionate numbers.

In a paper published Dec. 5 in Nature Medicine, Fernando Polack, M.D., the Cesar Milstein Associate Professor of Pediatrics at Vanderbilt, and colleagues in Argentina and Nashville provide a possible explanation for this alarming phenomenon of pandemic flu. The study's findings suggest people are made critically ill, or even killed, by their own immune response.

"Every time there is an influenza pandemic there is a large proportion of younger, or middle-aged adults who die. We have always explained these deaths, based on presumed virulence of virus, or getting bacterial infection at the same time. We now have vaccines and antibiotics, but still we see middle-aged individuals who die," Polack said.

Polack directs the INFANT Foundation, a research and clinical institute based in Buenos Aires, in close cooperation with Vanderbilt's Vaccine Center. In Argentina, he had a front row seat for the emergence of the H1N1 flu pandemic, which began in April 2009.

As the H1N1 virus burned its way northward through the southern hemisphere, Polack and his team went to work looking for evidence of a biomarker he had used before. A biomarker is a protein that can be measured in blood or tissue whose concentration reflects the severity or presence of some disease state.

"We have seen this before. Where non-protective antibody responses are associated with an immune-based disease in the lung," Polack said.

Polack has previously published evidence that a first-line immune response, primed by an imperfect antibody, can overreact in a violent and uncontrolled fashion. Patients die from lung damage inflicted by their own immune system. A molecule called C4d, a product of this biochemical cascade (the complement system), is a marker for the strength of the response.

In adults who died during the 2009 H1N1 pandemic, high levels of C4d in lung tissues suggest a massive, potentially fatal activation of the complement system.

Pulmonary and critical care physician, Todd Rice, M.D., assistant professor of Medicine at VUMC, has seen people killed by the "exuberant" and uncontrolled response of the immune system in other diseases – like sepsis.

"This looked every bit like that," Rice recalled about H1N1 patients, including Jason Martin, who piled into his intensive care unit in mid-September, 2009. "It was impressive. These were as sick as any patients I had ever seen. We tried all sorts of things," Rice said.

Ultimately, Vanderbilt's ICU saw 49 adults with H1N1, most ages 25 to 45. Jason Martin was one of 40 who survived.

But Polack wanted evidence beyond what he saw in patients in 2009. He asked Joyce Johnson, M.D., professor of Pathology with VUMC, to look for evidence this phenomenon may have happened during past flu pandemics. Johnson scanned Vanderbilt's hand-penned autopsy ledgers, dating back to 1925. She was able to locate tissue samples in Vanderbilt's tissue archive and extract half a dozen slices of lung tissue from Nashville patients who died during the 1957 Hong Kong flu pandemic.

Pediatric infectious diseases expert, John Williams, M.D., assistant professor of Pediatrics, Microbiology & Immunology, and his lab found the signature for an influenza infection in 4 of the 53-year-old samples, and were able to confirm the lung tissues had high levels of C4d. These patients too had died from an over-reactive immune response.

"C4d is part of the inflammatory cascade, and while it's really good at killing organisms and protecting us, it's sort of the slash and burn approach, capable of causing lots of tissue damage," Johnson said.

But why did infants and the frail elderly escape this mechanism of death in the H1N1 pandemic?

"We found in 2009, the elderly had good immunity because they had seen a very similar virus sometime before 1957. Babies hadn't seen many viruses at all so there was no trigger. It came down to the young adults – primed with an ineffective response. Their bodies already had defenses against previous influenza viruses that look like this one but weren't close enough," Polack said.

While the patient sample in the current study is relatively small: 75 patients, including 23 who died in 2009, and 4 from 1957, investigators were able to show that other theories, like dampening of interferon, or the triggering of an inflammatory response called a "cytokine storm," were not supported by the evidence. Even the number of viruses present in a flu patient did not seem to correlate with the severity of illness.

"It suggests this (immune over-reaction) is what happens with pandemic to make young healthy adults seriously ill. There are other things that contribute to threat, but this is one of the main things for this age group," Polack said.

While many questions remain, one thing is clear: the H1N1 vaccine offers protection. Patients who died were overwhelmingly unvaccinated. Many fell ill before a vaccine was even available.

A study of genetics will be among the next steps to explain responses experienced by people like Jason Martin. It may be possible to find out who is susceptible to this over-reactive response so they can actively avoid exposure, or receive a specific regimen of treatment. But until then, vaccination is the best idea.

Carole Bartoo | EurekAlert!
Further information:
http://www.vanderbilt.edu

More articles from Health and Medicine:

nachricht Observing the cell's protein factories during self-assembly
15.06.2018 | Charité - Universitätsmedizin Berlin

nachricht Scientists unravel molecular mechanisms of Parkinson's disease
13.06.2018 | The Francis Crick Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: AchemAsia 2019 will take place in Shanghai

Moving into its fourth decade, AchemAsia is setting out for new horizons: The International Expo and Innovation Forum for Sustainable Chemical Production will take place from 21-23 May 2019 in Shanghai, China. With an updated event profile, the eleventh edition focusses on topics that are especially relevant for the Chinese process industry, putting a strong emphasis on sustainability and innovation.

Founded in 1989 as a spin-off of ACHEMA to cater to the needs of China’s then developing industry, AchemAsia has since grown into a platform where the latest...

Im Focus: First real-time test of Li-Fi utilization for the industrial Internet of Things

The BMBF-funded OWICELLS project was successfully completed with a final presentation at the BMW plant in Munich. The presentation demonstrated a Li-Fi communication with a mobile robot, while the robot carried out usual production processes (welding, moving and testing parts) in a 5x5m² production cell. The robust, optical wireless transmission is based on spatial diversity; in other words, data is sent and received simultaneously by several LEDs and several photodiodes. The system can transmit data at more than 100 Mbit/s and five milliseconds latency.

Modern production technologies in the automobile industry must become more flexible in order to fulfil individual customer requirements.

Im Focus: Sharp images with flexible fibers

An international team of scientists has discovered a new way to transfer image information through multimodal fibers with almost no distortion - even if the fiber is bent. The results of the study, to which scientist from the Leibniz-Institute of Photonic Technology Jena (Leibniz IPHT) contributed, were published on 6thJune in the highly-cited journal Physical Review Letters.

Endoscopes allow doctors to see into a patient’s body like through a keyhole. Typically, the images are transmitted via a bundle of several hundreds of optical...

Im Focus: Photoexcited graphene puzzle solved

A boost for graphene-based light detectors

Light detection and control lies at the heart of many modern device applications, such as smartphone cameras. Using graphene as a light-sensitive material for...

Im Focus: Water is not the same as water

Water molecules exist in two different forms with almost identical physical properties. For the first time, researchers have succeeded in separating the two forms to show that they can exhibit different chemical reactivities. These results were reported by researchers from the University of Basel and their colleagues in Hamburg in the scientific journal Nature Communications.

From a chemical perspective, water is a molecule in which a single oxygen atom is linked to two hydrogen atoms. It is less well known that water exists in two...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Munich conference on asteroid detection, tracking and defense

13.06.2018 | Event News

2nd International Baltic Earth Conference in Denmark: “The Baltic Sea region in Transition”

08.06.2018 | Event News

ISEKI_Food 2018: Conference with Holistic View of Food Production

05.06.2018 | Event News

 
Latest News

A sprinkle of platinum nanoparticles onto graphene makes brain probes more sensitive

15.06.2018 | Materials Sciences

100 % Organic Farming in Bhutan – a Realistic Target?

15.06.2018 | Ecology, The Environment and Conservation

Perovskite-silicon solar cell research collaboration hits 25.2% efficiency

15.06.2018 | Power and Electrical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>